Company Filing History:

6 out of 83

Immuno Aktiengesellschaft

patents

5 out of 36

Immuno Aktiengesellschaft Fur Chemisch-medizinische Produkte

patents

1 out of 67

Baxter Aktiengesellschaft

patents

Years Active: 1983-2002

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6403556 - Pharmaceutical preparation containing protein C and a thrombolytically active substance (2002-06-11),

2. 5830467 - Pharmaceutical preparation containing protein C and a thrombolytically (1998-11-03),

3. 5776452 - Thrombosis agent (1998-07-07),

4. 5580962 - Parenterally administrable drug having thrombolytic activity and (1996-12-03),

5. 5478558 - Method of dissolving venous Thrombi using drug containing activated (1995-12-26),

6. 5330907 - Method of preparing activated protein C (1994-07-19),

7. 5304383 - Pharmaceutical preparation based on Lys-plasminogen (1994-04-19),

8. 4904641 - Method of inactivating reproducible filterable pathogens in blood plasma (1990-02-27),

9. 4687664 - Method of inactivating reproducible pathogens (1987-08-18),

10. 4640834 - Method of inactivating reproducible filterable pathogens in blood (1987-02-03),

11. 4608254 - Method for the production of therapeutically administrable plasma (1986-08-26),

12. 4395396 - Blood-coagulation-promoting preparation based on human proteins and a (1983-07-26),

Title: The Innovative Contributions of Anton Philapitsch

Introduction

Anton Philapitsch, an accomplished inventor based in Ebenfurt, Austria, has made significant strides in the field of pharmaceuticals. With a total of 12 patents to his name, his work primarily focuses on advancements in thrombolysis therapy, demonstrating a commitment to enhancing medical treatments.

Latest Patents

Among his notable inventions are two similar patents for a pharmaceutical preparation containing protein C and a thrombolytically active substance that does not activate protein C. This innovative preparation plays an essential role in preventing reocclusion, a common complication during thrombolysis therapy. Philapitsch's contributions are pivotal in improving patient outcomes in this therapeutic area.

Career Highlights

Philapitsch has spent a significant portion of his career at reputable companies like Immuno Aktiengesellschaft and Immuno Aktiengesellschaft Für Chemisch-Medizinische Produkte. His work in these organizations has allowed him to develop and refine his groundbreaking inventions, underscoring his expertise and dedication to pharmaceutical innovation.

Collaborations

Throughout his career, Anton Philapitsch has collaborated with esteemed colleagues, including Johann J. Eibl and Hans Peter Schwarz. These partnerships have fostered an environment of creativity and innovation, furthering their collective goal of advancing medical science.

Conclusion

Anton Philapitsch's contributions to the field of pharmaceuticals are noteworthy and impactful. With his innovative patents and collaborative spirit, he continues to drive forward the boundaries of medical treatment. His work embodies the essence of innovation, and his inventions are likely to have a lasting positive influence on thrombolysis therapy and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.